Biologyarticle2026-11-13

Enhancer-targeted CRISPR-A rescues haploinsufficiency and mutant phenotypes in organoid models of autism

Open access12 citations

Abstract

Abstract Autism spectrum disorder (ASD) is a highly heritable condition with diverse clinical presentations. Approximately 15% of the genetic susceptibility of ASD is imparted by de novo haploinsufficient mutations of major effect. We mapped enhancers of two high-confidence autism genes, CHD8 and SCN2A , and used CRISPR-based gene activation targeting enhancers (eCRISPR-A) in human pluripotent stem cell (hPSC)-derived excitatory neurons and cerebral forebrain organoids to correct the effects of haploinsufficiency, taking advantage of the presence of a wild-type allele of each gene and endogenous gene regulation. Here we show that eCRISPR-A induced a sustained increase in CHD8 and SCN2A expression specifically in mutant neurons and cortical organoids, with rescue of gene expression levels and mutation-associated phenotypes, including gene expression and physiology. These data support gene activation via targeting enhancers of haploinsufficient genes as a therapeutic intervention in ASD and other neurodevelopmental disorders.

// Source

View paper (DOI)Open access versionOpenAlexNature NeurosciencePublished 2026-11-13

Authors: George T Chen, Aubrey J. Osorio, Sandra M. Holley, Kimiya Ghassemzadeh, Congyi Lu, Neville E. Sanjana, Carlos Cepeda, Daniel H. Geschwind

Institutions: University of California, Los Angeles, New York University, New York Genome Center